Product NDC: | 65649-601 |
Proprietary Name: | Visicol |
Non Proprietary Name: | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, AND SODIUM PHOSPHATE, DIBASIC ANHYDROUS |
Active Ingredient(s): | .398; 1.102 g/1; g/1 & nbsp; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, AND SODIUM PHOSPHATE, DIBASIC ANHYDROUS |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65649-601 |
Labeler Name: | Salix Pharmaceuticals, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021097 |
Marketing Category: | NDA |
Start Marketing Date: | 20001001 |
Package NDC: | 65649-601-41 |
Package Description: | 100 TABLET in 1 BOTTLE (65649-601-41) |
NDC Code | 65649-601-41 |
Proprietary Name | Visicol |
Package Description | 100 TABLET in 1 BOTTLE (65649-601-41) |
Product NDC | 65649-601 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, AND SODIUM PHOSPHATE, DIBASIC ANHYDROUS |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20001001 |
Marketing Category Name | NDA |
Labeler Name | Salix Pharmaceuticals, Inc |
Substance Name | SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
Strength Number | .398; 1.102 |
Strength Unit | g/1; g/1 |
Pharmaceutical Classes |